SCHEMBL29936009

SCHEMBL29936009

Cc1cnn2cccc(C=O)c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.42
TSHR P16473 1/20 0.42
EPHB3 P54753 2/20 0.37
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35
THRB P10828 1/20 0.35
BLM P54132 1/20 0.35
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
DRD2 P14416 2/20 0.33
DRD4 P21917 2/20 0.33
DRD3 P35462 2/20 0.33
TRIM24 O15164 4/20 0.32
TRIM33 Q9UPN9 4/20 0.32
KDM4E B2RXH2 1/20 0.31
MAPT P10636 1/20 0.31
RECQL P46063 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
NPC1 O15118 2/20 0.30
RAB9A P51151 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3079162 0.86 EPHB3 (0.43) ALDH1A1TSHREPHB3MEN1LMNA
SCHEMBL29935840 0.79 ERN1 (0.38) ALDH1A1TSHREPHB3MEN1LMNA
SCHEMBL21236685 0.77 EPHB3 (0.46) TSHREPHB3LMNADRD2DRD4
SCHEMBL31150987 0.76 L3MBTL1 (0.43) ALDH1A1EPHB3TDP1MAPT
SCHEMBL29935836 0.73 ERN1 (0.44) ALDH1A1TSHRLMNATDP1DRD2
SCHEMBL26779056 0.73 EPHB3 (0.37) EPHB3DRD2DRD4DRD3
SCHEMBL22667034 0.73 AXL (0.39) ALDH1A1EPHB3DRD2DRD4DRD3
SCHEMBL26779062 0.73 EPHB3 (0.40) EPHB3LMNADRD2DRD4DRD3
SCHEMBL20220530 0.73 EPHB3 (0.37) ALDH1A1EPHB3DRD2DRD4DRD3
SCHEMBL24566312 0.72 ERN1 (0.38) ALDH1A1EPHB3MEN1LMNATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113164459-B Monoacylglycerol lipase modulators 詹森药业有限公司 2024-09-03 CN claimed
US-12577243-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2026-03-17 US disclosed
CN-113164459-B Monoacylglycerol lipase modulators 詹森药业有限公司 2024-09-03 CN disclosed
US-11820766-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-11-21 US disclosed
US-20230145249-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2023-05-11 US disclosed
US-20220332713-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2022-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220332713-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP ALDH1A1 312/4885TSHR 909/4885EPHB3 3524/4885
US-12577243-B2 Monoacylglycerol lipase modulators MGLL, LPL, FAAH ALDH1A1 587/4885TSHR 400/4885EPHB3 1882/4885
US-20230145249-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP ALDH1A1 312/4885TSHR 909/4885EPHB3 3524/4885
US-11820766-B2 Monoacylglycerol lipase modulators MGLL, LPL, PNLIP ALDH1A1 312/4885TSHR 909/4885EPHB3 3524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.